Statin Therapy Results in the Real World Practice in the Czech Republic

Completed

• Conditions: Dyslipidaemia

• Registration Number: NCT01055977
• Lead Sponsor: AstraZeneca

Brief Summary

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.

The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-01-25
• Study First Submitted QC: 2010-01-25
• Study First Posted: 2010-01-26
• Study Start: 2010-02
• Primary Completion: 2010-06
• Study Completion: 2010-06
• Status Verified: 2011-08
• Last Update Submitted: 2011-08-29
• Last Update Posted: 2011-08-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3253

Inclusion Criteria

• Documented statin therapy for at least 12 months
• Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
LDL-C	one year

Secondary Outcome Measures

Name	Time	Method
Total cholesterol	one year
HDL-C	one year
triglycerides	one year

Trial Locations

Locations (1)

Research Site; 🇨🇿 Znojmo, Czech Republic